Methods: We tested 143 biological samples from pediatric patients with SLE from the French national lupus biobank and performed IFN-α2 dosage (ELISA) and functionally tested the inhibitory capacities of each sera sample on IFN activity. The gene discussed is IFNA2; the disease is systemic lupus erythematosus.